Precision Antibody to Develop Monoclonal Antibodies for NCI

The company will develop the cancer-targeted antibodies for SAIC-Frederick under an NCI proteomics initiative.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories